Muscle News and Research

RSS

Study reveals maternal and neonatal benefits of Pfizer COVID-19 mRNA vaccine

A new commentary, published as an ‘In-Press Preview’ in the Journal of Clinical Investigation, addresses the salient issue of vaccination against the coronavirus disease (COVID-19) in pregnancy and potential antibody transfer to the fetus – and provides the evidence in support of messenger RNA (mRNA) vaccine safety and efficacy for both maternal and child health.

13 Jun 2021

Calcified Tissue International announces top 10 most impactful papers of 2019

Calcified Tissue International and Musculoskeletal Research is among the leading peer-reviewed journals publishing original preclinical, translational, and clinical research as well as expert reviews in the bone and musculoskeletal field.

13 Jun 2021

Special dipping solution can significantly extend the shelf life of “side streams”

When herring are filleted, more than half their weight becomes a low-value 'side stream' that never reaches our plates - despite being rich in protein and healthy omega-3 fatty acids.

11 Jun 2021

Systemic biomarkers show beneficial effects of aerobic exercise on brain function in older adults

Increasing evidence shows that physical activity and exercise training may delay or prevent the onset of Alzheimer's disease (AD). In aging humans, aerobic exercise training increases gray and white matter volume, enhances blood flow, and improves memory function.

10 Jun 2021

Soft diets may alter the brain's control of chewing, study finds

Incoming sensory information can affect the brain's structure, which may in turn affect the body's motor output. However, the specifics of this process are not always well understood.

9 Jun 2021

New cell-penetrating peptide may protect against life-threatening microbial inflammation

A cell-penetrating peptide developed by researchers at Vanderbilt University Medical Center can prevent, in an animal model, the often-fatal septic shock that can result from bacterial and viral infections.

9 Jun 2021

QurAlis gears up for clinical development of therapeutic candidate, QRL-101

(BUSINESS WIRE)--QurAlis Corporation, a biotech company developing breakthrough precision medicines for ALS and other genetically validated neurodegenerative diseases, today announced the publication of an article in Cell Reports.

9 Jun 2021

New resin acid molecules have promising properties as potential drugs against epilepsy

New molecules, developed by researchers at Linköping University, have promising properties as possible drugs against epilepsy.

8 Jun 2021

Researchers find new insight on the link between a gene and congenital heart disease

New insight on the link between a gene called SORBS2 and congenital heart disease has been published today in eLife, with findings that may help explain the cause of the disease in some patients.

8 Jun 2021

Kidney experts say it’s time to remove race from medical algorithms. Doing so is complicated.

Alphonso Harried recently came across a newspaper clipping about his grandfather receiving his 1,000th dialysis treatment. His grandfather later died — at a dialysis center — as did his uncle, both from kidney disease.

8 Jun 2021

Discovery offers a potential new pathway to treat hypertension

High blood pressure, or hypertension, is the leading modifiable risk factor for cardiovascular diseases and premature death worldwide.

7 Jun 2021

UVA researchers discover potential treatment approaches for muscle loss in myotonic dystrophy type 1

University of Virginia School of Medicine researchers have identified new insights and potential treatment approaches for muscle loss in myotonic dystrophy type 1 (DM1), the most common form of muscular dystrophy.

7 Jun 2021

COVID-19 symptoms in the feet

In a review paper recently uploaded to the Journal of Clinical Medicine by Jimenez-Cebrian et al. (May 19th, 2021), the clinical manifestations of COVID-19 in feet, in particular, are reviewed, finding that vascular, dermatological, and neurological symptoms have been widely reported.

6 Jun 2021

Metformin potently inhibits SARS-CoV-2-induced cytokine release in monocytes

An interesting new bioRxiv* preprint reports the suppression of monocyte glycolysis and cytokine production when exposed to the virus, following pretreatment with the commonly used drug, metformin.

6 Jun 2021

Mental health effects common among mild and severe cases of COVID-19

Findings on mental health outcomes of COVID-19 infection show frequent symptoms associated with lasting neurological symptoms.

4 Jun 2021

Regular strength and impact-type training may counteract bone aging

Regular strength and impact-type training may decrease or even prevent age-related bone deterioration in men, new research at the University of Jyväskylä, Finland, shows.

3 Jun 2021

NIH supports a new strategy to reduce side effects of head and neck cancer treatment

A new strategy to reduce the side effects suffered by patients undergoing treatment for head and neck cancers now has the support of the National Institutes of Health.

2 Jun 2021

Study uncovers mechanisms by which microRNAs drive atherogenesis in a cell-type-specific manner

Researchers at the University of Eastern Finland have uncovered potential mechanisms by which microRNAs (miRNA) drive atherogenesis in a cell-type-specific manner.

2 Jun 2021

Could higher carnitine levels in the blood protect against severe COVID-19?

Researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK, found that carnitine and its derivative acetyl-carnitine provide a protective effect against severe COVID-19. Doubling of carnitine or acetyl-carnitine is tied to a 40-percent reduction risk of disease progression.

2 Jun 2021

Study identifies protein that could be the key to improving heart attack treatment outcomes

A new study led by researchers at Washington State University has identified a protein that could be the key to improving treatment outcomes after a heart attack.

2 Jun 2021

Muscle News and Research

Study reveals maternal and neonatal benefits of Pfizer COVID-19 mRNA vaccine

Calcified Tissue International announces top 10 most impactful papers of 2019

Special dipping solution can significantly extend the shelf life of “side streams”

Systemic biomarkers show beneficial effects of aerobic exercise on brain function in older adults

Soft diets may alter the brain's control of chewing, study finds

New cell-penetrating peptide may protect against life-threatening microbial inflammation

QurAlis gears up for clinical development of therapeutic candidate, QRL-101

New resin acid molecules have promising properties as potential drugs against epilepsy

Researchers find new insight on the link between a gene and congenital heart disease

Kidney experts say it’s time to remove race from medical algorithms. Doing so is complicated.

Discovery offers a potential new pathway to treat hypertension

UVA researchers discover potential treatment approaches for muscle loss in myotonic dystrophy type 1

COVID-19 symptoms in the feet

Metformin potently inhibits SARS-CoV-2-induced cytokine release in monocytes

Mental health effects common among mild and severe cases of COVID-19

Regular strength and impact-type training may counteract bone aging

NIH supports a new strategy to reduce side effects of head and neck cancer treatment

Study uncovers mechanisms by which microRNAs drive atherogenesis in a cell-type-specific manner

Could higher carnitine levels in the blood protect against severe COVID-19?

Study identifies protein that could be the key to improving heart attack treatment outcomes

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News